## EQT: EQT Corporation - XLE: Energy

### Executive Summary

VALUE thesis: PEG 0.37 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($54.48)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. EQT Corp. stock underperforms Tuesday when compared to competitors**
- Source: MarketWatch | 20251202T165700 | Neutral | Relevance: 97%
-  Shares of EQT Corp. (EQT) fell by 3.17% to $58.60 on Tuesday, despite a generally positive day for the stock market where the S&P 500 Index and Dow Jones Industrial Average both saw gains. This marked the second consecutive day of losses for the company's stock, underperforming its competitors. The article was generated by MarketWatch Automation, leveraging market data from Dow Jones and FactSet.

**2. EQT Corporation (EQT) is a Top-Ranked Growth Stock: Should You Buy?**
- Source: www.sharewise.com | 20251202T144519 | Bullish | Relevance: 97%
- This article analyzes EQT Corporation (EQT) as a top-ranked growth stock using Zacks' proprietary rating system, including the Zacks Rank and Style Scores for Value, Growth, Momentum, and VGM. It explains how these metrics help investors identify stocks with the highest potential for outperformance. EQT is highlighted as a strong candidate for growth investors, with a Growth Style Score of B and forecasted year-over-year earnings growth of 80.1%.

**3. Has Civitas Resources' (CIVI) Efficiency Drive Unlocked a New Competitive Edge?**
- Source: Simply Wall Street | 20251201T053019 | Neutral | Relevance: 57%
- Civitas Resources (CIVI) reported a 6% increase in third-quarter production and a 5% reduction in cash operating costs, showcasing improved efficiency. While this operational enhancement is positive, the pending merger with SM Energy is the primary factor influencing the stock's future. The article suggests that regulatory challenges in its core basins remain a significant risk for the company.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | Scotiabank | $67 | $70 | -4% |
| 2025-11-18 | Piper Sandler | $50 | $49 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | Scotiabank | main | Sector Perform |
| 2025-11-18 | Piper Sandler | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.06M) |
| Sells | 2 ($3.56M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+6.2%)
- Blackrock Inc.: 7.7% (+1.1%)
- Wellington Managemen: 6.8% (-1.4%)
- State Street Corpora: 5.4% (+3.4%)
- Morgan Stanley: 3.8% (+12.3%)

### Key Risks

1. Insider selling cluster: $3.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.37 indicates undervaluation relative to growth. Forward P/E 13.4x attractive for 52% earnings growth. Quality metrics strong (margin 23%). Insider selling cluster ($3.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.7B |
| Beta | 0.62 |
| 52W Range | $42.27 - $62.23 |
| Short Interest | 3.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.37 |
| Forward P/E | 13.4 |
| Current P/E | 20.3 |
| YoY Growth | 52.2% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -0.5% to -1.5% (-1.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.5pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 54.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.54% (CS: 40) | Neutral |
| RSI_14 | 53.9 | Neutral |
| MACD Histogram | -0.03 | Bearish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.092x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $58.60
- **Stop Loss:** $54.48 (7.0% risk)
- **Target:** $66.84 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 121
- **Position Value:** $7,090.60
- **Portfolio %:** 7.09%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-17 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.36 | $0.52 | +42.8% |
| 2025Q2 | $0.41 | $0.45 | +10.0% |
| 2025Q1 | $1.01 | $1.18 | +16.6% |
| 2024Q4 | $0.53 | $0.69 | +31.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*